Oryzon to invest eur 20 million to develop new drugs
Catalan Economy
10 Sep 2009
Biotech company oryzon genomics has announced a four-year program to invest eur 20 million in the development of new drugs. oryzon ceo carlos buesa indicated that the company would use the resources to strengthen its research on biomarkers and antibody therapy.
oryzon recently opened its new 2,300-square-meter corporate headquarters in cornellà de llobregat (barcelona), with an investment of eur 2.5 million. the company expects revenue of eur 8 million for its current fiscal year.
source: expansión catalunya, 08/09/09
Related News and Success stories.
-
01 Dec 2025
See more UK investment in Catalonia reaches over €200 million during the first half of 2025UK investment in Catalonia reaches over €200 million during the first half of 2025
-
28 Nov 2025
See more Daren Tang, Director General of WIPO: “Barcelona’s innovation model works like an orchestra”Daren Tang, Director General of WIPO: “Barcelona’s innovation model works like an orchestra”
-
12 Nov 2025
See more Sateliot launches the first European 5G Satellite Development Center in BarcelonaSateliot launches the first European 5G Satellite Development Center in Barcelona
-
11 Nov 2025
See more Catalonia launches €1 billion AI Strategy to drive innovation, competitiveness, and responsible growth by 2030Catalonia launches €1 billion AI Strategy to drive innovation, competitiveness, and responsible growth by 2030
